Startups Versus Incumbents: Who Will Win the Go-to-Market AI Race?

Published on June 22, 2023

“Who will win the go-to-market AI race?”

I’ve been studying this question closely over the last 6 months. I’ve enjoyed countless debates with go-to-market leaders from the largest public companies all the way down to pre-product, pre-revenue startups with talented AI tech teams. More recently, at Stage 2 Capital, we rolled out the Go-To-Market AI Lab to understand and accelerate innovation in the ecosystem. Within a week, 100+ CROs/CMOs/CCOs opted in to evaluate the AI tech we are seeing and 200+ AI startups submitted their ideas with the hopes of meetings, tests, and early customers with these leaders.  

We hope in the weeks to come, we can report back on quantitative trends in buyer sentiment, innovation concentration, and early success stories. In the meantime, I’d like to share the anecdotal trends I heard, first about AI in general, and then about trends specific to go-to-market. 

Continue reading on website
Other news

Why We Led AptEdge's $11M Seed Round

June 15, 2023
We are pleased to announce we led AptEdge’s $11M seed round alongside Unusual Ventures, National Grid Partners, Carya Venture Partners, Counterpart Ventures. You can read more in AptEdge’s announcement here. AptEdge is changing the way support and service teams put out daily fires and get answers to customer questions. They’ve launched AnswerGPT™ which pulls together data sources stored across dis

Why We Led MedScout’s $5M Seed Round

June 28, 2023
We are thrilled to share that we led a $5 million Seed Investment into MedScout, joined by our friends at LiveOak Venture Partners, Alumni Ventures and a16z Scout Fund. You can read MedScout’s official announcement here.Historically, sales for medical technology and life sciences companies have been very people and live-interactions heavy. In fact, these companies spend, on average, 2-3x more on S